Range Low Price High Price Comment
30 days $2.63 $3.38 Tuesday, 30th Apr 2024 AYTU stock ended at $2.81. During the day the stock fluctuated 2.88% from a day low at $2.81 to a day high of $2.89.
90 days $2.48 $3.40
52 weeks $1.38 $3.50

Historical Aytu Bioscience prices

Date Open High Low Close Volume
Feb 16, 2024 $3.17 $3.40 $3.10 $3.17 44 956
Feb 15, 2024 $3.21 $3.30 $3.10 $3.12 22 720
Feb 14, 2024 $3.00 $3.40 $3.00 $3.15 105 681
Feb 13, 2024 $2.85 $2.99 $2.85 $2.99 30 392
Feb 12, 2024 $2.85 $2.95 $2.85 $2.93 30 403
Feb 09, 2024 $2.66 $2.93 $2.66 $2.87 33 812
Feb 08, 2024 $2.57 $2.76 $2.54 $2.65 4 310
Feb 07, 2024 $2.56 $2.61 $2.53 $2.53 3 641
Feb 06, 2024 $2.48 $2.58 $2.48 $2.51 6 668
Feb 05, 2024 $2.80 $2.80 $2.50 $2.53 17 524
Feb 02, 2024 $2.67 $2.67 $2.64 $2.64 6 730
Feb 01, 2024 $2.66 $2.69 $2.66 $2.67 8 177
Jan 31, 2024 $2.85 $2.85 $2.73 $2.73 12 114
Jan 30, 2024 $2.78 $2.85 $2.77 $2.85 4 523
Jan 29, 2024 $2.76 $2.85 $2.76 $2.85 4 553
Jan 26, 2024 $2.75 $2.85 $2.75 $2.85 13 349
Jan 25, 2024 $2.68 $2.73 $2.63 $2.73 9 217
Jan 24, 2024 $2.72 $2.75 $2.58 $2.74 5 265
Jan 23, 2024 $2.76 $2.79 $2.70 $2.75 3 882
Jan 22, 2024 $2.57 $2.92 $2.44 $2.82 32 829
Jan 19, 2024 $2.51 $2.58 $2.42 $2.53 22 526
Jan 18, 2024 $2.41 $2.50 $2.37 $2.46 18 184
Jan 17, 2024 $2.45 $2.50 $2.45 $2.50 14 094
Jan 16, 2024 $2.53 $2.57 $2.49 $2.49 14 996
Jan 12, 2024 $2.62 $2.62 $2.56 $2.56 5 890
Click to get the best stock tips daily for free!

About Aytu Bioscience

Aytu Bioscience Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the... AYTU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT